This article is more than 5 years old. Information may no longer be current.

FDA clears new B. Braun dialyzer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The U.S. Food and Drug Administration has cleared B. Braun Medical Inc.’s new hemodialyzer Diacap Pro, which the company said has improved clearance performance and user handling.

The new dialyzer has a lower comparable surface area and an increased molecule to surface contact.

“The newly developed fibers in Diacap Pro are designed to improve dialysis dose,” said Samuel Amory, Vice President at B. Braun Medical. “The Diacap Pro fibers clear blood toxins like urea and creatinine, while still retaining vital molecules like albumin.”

Diacap Pro is available in three sizes: 1.3m², 1.6m², 1.9m².